Building general image

Healthcare & Life Sciences

Healthcare & Life Sciences

Healthcare & Life Sciences

Download PDFDownload PDF
Print
Share

Overview

Paving the way for cutting-edge industry transformation

BCLP’s global Healthcare team is a leader in providing legal services to the healthcare industry. We use our experience in the healthcare industry to help you to:

  • achieve strategic goals;
  • provide practical, business-focused guidance on regulatory compliance and operational issues;
  • developing and executing complex transactions; and
  • representing you in commercial litigation.

As healthcare continues to be transformed by technological advances and an ever-changing regulatory environment, we know you trust us to advise you on cutting-edge, transformational matters including telemedicine, health IT, transparency, and alternative payment methodologies.

We represent a large spectrum of global industry participants from medical device companies, hospitals and health systems to private equity and other investors.

Our cross-discipline approach combines capabilities in compliance, privacy and data security, transactions, real estate government investigations, litigation, corporate, finance, tax, intellectual property and regulatory areas. As a result, we have a thorough understanding, not only of the legal and business issues, but also of the policies and principles that underlie and influence the healthcare sector, ensuring that you receive the best possible support and guidance.

 

one of the world’s leading competition practices

Competition Review 

Related Insights

Insights
May 16, 2024

Navigating the FemTech regulatory landscape

Security, scale or functionality – pick two. This computer science principle coined by the late Professor Anderson is particularly relevant to the FemTech industry. Anderson’s Rule states that for a system to provide high functionality and security, its access may need to be limited (small scale); alternatively, offering high functionality on a larger scale, may require an acceptance of risk, e.g. of inadvertent or deliberate disclosure of information. In real life systems - including FemTech - a balance must be struck. It is no surprise, then, that the regulatory landscape for FemTech is complex and fragmented. Different juris…

Related Insights

News
Feb 28, 2025
BCLP’s David B. Schwartz Featured on Our Curious Amalgam Podcast to Discuss Healthcare Information Blocking
News
Feb 24, 2025
BCLP Lawyers Examine Diverging U.S. and EU Approaches to Sustainability Agreements in Competition Policy International
News
Feb 24, 2025
BCLP Partner and Former FTC Attorney Comments on FTC Chair Andrew Ferguson’s ABA Ban
News
Feb 12, 2025
BCLP Partner Quoted in Bloomberg on FTC’s Litigation Challenges
Blog Post
Dec 16, 2024
Trump Controlling the FTC? Picks for FTC Chair and FTC Commissioner Signal Significant Changes
News
Oct 09, 2024
BCLP advises OrbiMed on restructuring and financing agreement with listed company Poxel
Insights
Jul 19, 2024
Navigating the FemTech regulatory landscape: best practice & future developments
News
May 30, 2024
Partner Amy de Lama and Associate Andrea Rastelli share insights on Washington My Health My Data Act FAQs: Data Subject Rights
Insights
May 16, 2024
Navigating the FemTech regulatory landscape
Security, scale or functionality – pick two. This computer science principle coined by the late Professor Anderson is particularly relevant to the FemTech industry. Anderson’s Rule states that for a system to provide high functionality and security, its access may need to be limited (small scale); alternatively, offering high functionality on a larger scale, may require an acceptance of risk, e.g. of inadvertent or deliberate disclosure of information. In real life systems - including FemTech - a balance must be struck. It is no surprise, then, that the regulatory landscape for FemTech is complex and fragmented. Different juris…